Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion NewsbysupervisorDecember 6, 20231 minute readNo comments
Concerns about the 2024 GOP Presidential Nomination NewsbysupervisorDecember 6, 20232 minute readNo comments
News U.S. Futures Show Modest Growth U.S. futures for the S&P 500 and Dow Jones Industrial Average are exhibiting positive signs, with a slight… supervisorOctober 11, 2023 Read More